TY - JOUR AU - Isaacs, A. AU - Lindenmann, J. PY - 1957 DA - 1957// TI - Virus interference. I. the interferon JO - Proc R Soc Lond B Biol Sci VL - 147 ID - Isaacs1957 ER - TY - JOUR AU - O’Malley, J. A. AU - Nussbaum-Blumenson, A. AU - Sheedy, D. AU - Grossmayer, B. J. AU - Ozer, H. PY - 1982 DA - 1982// TI - Identification of the T cell subset that produces human gamma interferon JO - J Immunol VL - 128 ID - O’Malley1982 ER - TY - JOUR AU - Kotenko, S. V. AU - Gallagher, G. AU - Baurin, V. V. AU - Lewis-Antes, A. AU - Shen, M. AU - Shah, N. K. PY - 2003 DA - 2003// TI - IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex JO - Nat Immunol VL - 4 UR - https://doi.org/10.1038/ni875 DO - 10.1038/ni875 ID - Kotenko2003 ER - TY - JOUR AU - Sheppard, P. AU - Kindsvogel, W. AU - Xu, W. AU - Henderson, K. AU - Schlutsmeyer, S. AU - Whitmore, T. E. PY - 2003 DA - 2003// TI - IL-28, IL-29 and their class II cytokine receptor IL-28R JO - Nat Immunol VL - 4 UR - https://doi.org/10.1038/ni873 DO - 10.1038/ni873 ID - Sheppard2003 ER - TY - JOUR AU - Li, S. F. AU - Gong, M. J. AU - Zhao, F. R. AU - Shao, J. J. AU - Xie, Y. L. AU - Zhang, Y. G. PY - 2018 DA - 2018// TI - Type I Interferons: distinct biological activities and current applications for viral infection JO - Cell Physiol Biochem VL - 51 UR - https://doi.org/10.1159/000495897 DO - 10.1159/000495897 ID - Li2018 ER - TY - JOUR AU - Adalid-Peralta, L. AU - Godot, V. AU - Colin, C. AU - Krzysiek, R. AU - Tran, T. AU - Poignard, P. PY - 2008 DA - 2008// TI - Stimulation of the primary anti-HIV antibody response by IFN-alpha in patients with acute HIV-1 infection JO - J Leukoc Biol VL - 83 UR - https://doi.org/10.1189/jlb.1007675 DO - 10.1189/jlb.1007675 ID - Adalid-Peralta2008 ER - TY - JOUR AU - Oya, M. AU - Asakura, H. AU - Mizuno, R. AU - Marumo, K. AU - Murai, M. PY - 2005 DA - 2005// TI - Repeated regression of pulmonary metastases from renal cell carcinoma after treatment using different interferon-alpha preparations JO - Biomed Res VL - 26 UR - https://doi.org/10.2220/biomedres.26.135 DO - 10.2220/biomedres.26.135 ID - Oya2005 ER - TY - JOUR AU - Yurkovetsky, Z. R. AU - Kirkwood, J. M. AU - Edington, H. D. AU - Marrangoni, A. M. AU - Velikokhatnaya, L. AU - Winans, M. T. PY - 2007 DA - 2007// TI - Multiplex analysis of serum cytokines in melanoma patients treated with interferon-alpha2b JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-06-1805 DO - 10.1158/1078-0432.CCR-06-1805 ID - Yurkovetsky2007 ER - TY - JOUR AU - Gajewski, T. F. AU - Corrales, L. PY - 2015 DA - 2015// TI - New perspectives on type I IFNs in cancer JO - Cytokine Growth Factor Rev VL - 26 UR - https://doi.org/10.1016/j.cytogfr.2015.01.001 DO - 10.1016/j.cytogfr.2015.01.001 ID - Gajewski2015 ER - TY - JOUR AU - Bonetti, A. AU - Kim, S. PY - 1993 DA - 1993// TI - Pharmacokinetics of an extended-release human interferon alpha-2b formulation JO - Cancer Chemother Pharmacol VL - 33 UR - https://doi.org/10.1007/BF00686225 DO - 10.1007/BF00686225 ID - Bonetti1993 ER - TY - STD TI - Podobnik B, Helk B, Smilovic´ V, Škrajnar Š, Fidler K, Jevševar S, et al. Conjugation of PolyPEG to interferon alpha extends serum half-life while maintaining low viscosity of the conjugate. Bioconjug Chem. 2015;26:452–9. ID - ref11 ER - TY - JOUR AU - Meller, S. AU - Gerber, P. A. AU - Kislat, A. AU - Hevezi, P. AU - Göbel, T. AU - Wiesner, U. PY - 2015 DA - 2015// TI - Allergic sensitization to pegylated interferon-α results in drug eruptions JO - Allergy VL - 70 UR - https://doi.org/10.1111/all.12618 DO - 10.1111/all.12618 ID - Meller2015 ER - TY - JOUR AU - Nelson, D. R. AU - Rustgi, V. AU - Balan, V. AU - Sulkowski, M. S. AU - Davis, G. L. AU - Muir, A. J. PY - 2009 DA - 2009// TI - Safety and antiviral activity of albinterferon alfa-2b in prior interferon nonresponders with chronic hepatitis C JO - Clin Gastroenterol Hepatol VL - 7 UR - https://doi.org/10.1016/j.cgh.2008.10.035 DO - 10.1016/j.cgh.2008.10.035 ID - Nelson2009 ER - TY - JOUR AU - Zeuzem, S. AU - Sulkowski, M. S. AU - Lawitz, E. J. AU - Rustgi, V. K. AU - Rodriguez-Torres, M. AU - Bacon, B. R. PY - 2010 DA - 2010// TI - Albinterferon Alfa-2b was not inferior to pegylated interferon-alpha in a randomized trial of patients with chronic hepatitis C virus genotype 1 JO - Gastroenterology VL - 139 UR - https://doi.org/10.1053/j.gastro.2010.06.066 DO - 10.1053/j.gastro.2010.06.066 ID - Zeuzem2010 ER - TY - JOUR AU - Jansen, P. L. AU - Bruijne, J. PY - 2012 DA - 2012// TI - Controlled-release interferon alpha 2b, a new member of the interferon family for the treatment of chronic hepatitis C JO - Expert Opin Investig Drugs VL - 21 UR - https://doi.org/10.1517/13543784.2012.640671 DO - 10.1517/13543784.2012.640671 ID - Jansen2012 ER - TY - JOUR AU - Ceaglio, N. AU - Etcheverrigaray, M. AU - Kratje, R. AU - Oggero, M. PY - 2008 DA - 2008// TI - Novel long-lasting interferon alpha derivatives designed by glycoengineering JO - Biochimie VL - 90 UR - https://doi.org/10.1016/j.biochi.2007.10.013 DO - 10.1016/j.biochi.2007.10.013 ID - Ceaglio2008 ER - TY - JOUR AU - Fares, F. A. AU - Suganuma, N. AU - Nishimori, K. AU - LaPolt, P. S. AU - Hsueh, A. J. AU - Boime, I. PY - 1992 DA - 1992// TI - Design of a long-acting follitropin agonist by fusing the C-terminal sequence of the chorionic gonadotropin beta subunit to the follitropin beta subunit JO - Proc Natl Acad Sci U S A VL - 89 UR - https://doi.org/10.1073/pnas.89.10.4304 DO - 10.1073/pnas.89.10.4304 ID - Fares1992 ER - TY - JOUR AU - Furuhashi, M. AU - Shikone, T. AU - Fares, F. A. AU - Sugahara, T. AU - Hsueh, A. J. AU - Boime, I. PY - 1995 DA - 1995// TI - Fusing the carboxy-terminal peptide of the chorionic gonadotropin (CG) beta-subunit to the common alpha-subunit: retention of O-linked glycosylation and enhanced in vivo bioactivity of chimeric human CG JO - Mol Endocrinol VL - 9 ID - Furuhashi1995 ER - TY - JOUR AU - Ceaglio, N. AU - Gugliotta, A. AU - Tardivo, M. B. AU - Cravero, D. AU - Etcheverrigaray, M. AU - Kratje, R. PY - 2016 DA - 2016// TI - Improvement of in vitro stability and pharmacokinetics of hIFN-α by fusing the carboxyl-terminal peptide of hCG β-subunit JO - J Biotechnol VL - 221 UR - https://doi.org/10.1016/j.jbiotec.2016.01.018 DO - 10.1016/j.jbiotec.2016.01.018 ID - Ceaglio2016 ER - TY - JOUR AU - Ceaglio, N. AU - Etcheverrigaray, M. AU - Conradt, H. S. AU - Grammel, N. AU - Kratje, R. AU - Oggero, M. PY - 2010 DA - 2010// TI - Highly glycosylated human alpha interferon: an insight into a new therapeutic candidate JO - J Biotechnol VL - 146 UR - https://doi.org/10.1016/j.jbiotec.2009.12.020 DO - 10.1016/j.jbiotec.2009.12.020 ID - Ceaglio2010 ER - TY - JOUR AU - Yuan, W. M. AU - Zhang, R. AU - Zhang, Q. AU - Ma, F. L. AU - Wang, C. AU - Wang, Y. Z. PY - 2018 DA - 2018// TI - The generation and biological activity of a long-lasting recombinant human interferon-λ1 JO - Protein Eng Des Sel VL - 31 UR - https://doi.org/10.1093/protein/gzy029 DO - 10.1093/protein/gzy029 ID - Yuan2018 ER - TY - JOUR AU - Khan, M. A. AU - Hassan, N. AU - Ahmad, N. AU - Khan, M. I. AU - Zafar, A. U. AU - Khan, F. PY - 2014 DA - 2014// TI - Studies to analyse the relationship between IFNα2b gene dosage and its expression, using a Pichia pastoris-based expression system JO - Yeast VL - 31 UR - https://doi.org/10.1002/yea.2990 DO - 10.1002/yea.2990 ID - Khan2014 ER - TY - JOUR AU - Lu, X. AU - Wang, J. AU - Jin, X. AU - Zhu, J. PY - 2015 DA - 2015// TI - High-level expression of a novel liver-targeting fusion interferon with preferred Escherichia coli codon preference and its anti-hepatitis B virus activity in vivo JO - BMC Biotechnol VL - 15 UR - https://doi.org/10.1186/s12896-015-0177-1 DO - 10.1186/s12896-015-0177-1 ID - Lu2015 ER - TY - JOUR AU - Mangan, N. E. AU - Fung, K. Y. PY - 2012 DA - 2012// TI - Type I interferons in regulation of mucosal immunity JO - Immunol Cell Biol VL - 90 UR - https://doi.org/10.1038/icb.2012.13 DO - 10.1038/icb.2012.13 ID - Mangan2012 ER - TY - JOUR AU - Rodríguez, M. C. AU - Ceaglio, N. AU - Antuña, S. AU - Tardivo, M. B. AU - Etcheverrigaray, M. AU - Prieto, C. PY - 2017 DA - 2017// TI - High yield process for the production of active human α-galactosidase a in CHO-K1 cells through lentivirus transgenesis JO - Biotechnol Prog VL - 33 UR - https://doi.org/10.1002/btpr.2538 DO - 10.1002/btpr.2538 ID - Rodríguez2017 ER - TY - JOUR AU - Youngster, S. AU - Wang, Y. S. AU - Grace, M. AU - Bausch, J. AU - Bordens, R. AU - Wyss, D. F. PY - 2002 DA - 2002// TI - Structure, biology, and therapeutic implications of pegylated interferon alpha-2b JO - Curr Pharm Des VL - 8 UR - https://doi.org/10.2174/1381612023393242 DO - 10.2174/1381612023393242 ID - Youngster2002 ER - TY - JOUR AU - Yuan, W. M. AU - Zhang, W. J. AU - Ma, F. L. AU - Li, J. S. AU - Zhang, Q. AU - Zheng, L. S. PY - 2017 DA - 2017// TI - IFN-λ1 in CHO cells: its expression and biological activity JO - Cell Mol Biol Lett VL - 22 UR - https://doi.org/10.1186/s11658-017-0057-x DO - 10.1186/s11658-017-0057-x ID - Yuan2017 ER - TY - JOUR AU - Peng, F. W. AU - Duan, Z. J. AU - Zheng, L. S. AU - Xie, Z. P. AU - Gao, H. C. AU - Zhang, H. PY - 2007 DA - 2007// TI - Purification of recombinant human interferon-ε and oligonucleotide microarray analysis of interferon-ε regulated genes JO - Protein Expr Purif VL - 53 UR - https://doi.org/10.1016/j.pep.2006.12.013 DO - 10.1016/j.pep.2006.12.013 ID - Peng2007 ER -